Composition
- Active ingredients
- ESOMEPRAZOLE MAGNESIUM EQ 20MG BASE; NAPROXEN 500MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Strengths and forms
The FDA lists each strength of a product separately; these pages share one label.
- ESOMEPRAZOLE MAGNESIUM EQ 20MG BASE; NAPROXEN 500MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · Tablet, delayed releaseThis page
- ESOMEPRAZOLE MAGNESIUM EQ 20MG BASE; NAPROXEN 375MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · Tablet, delayed releaseNDA022511-002 · Discontinued
Official product information
Drugs@FDA lists the approved labels, letters and reviews for application NDA022511.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Brand name
- Vimovo
- Active substance
- esomeprazole magnesium
- Route
- Oral
- Dosage form
- Tablet, delayed release
- Applicant
- Horizon
- Status
- Discontinued
- FDA approval
- 30 Apr 2010
- Application
- NDA022511-001